Merck & Co., Inc.·4

May 6, 4:01 PM ET

Oosthuizen Johannes Jacobus 4

4 · Merck & Co., Inc. · Filed May 6, 2024

Insider Transaction Report

Form 4
Period: 2024-05-04
Oosthuizen Johannes Jacobus
President, U.S. Market
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-04$127.51/sh+912$116,28924,270.949 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-05-049120 total
    From: 2022-05-04Exp: 2024-05-04Common Stock (912 underlying)
  • Tax Payment

    Common Stock

    2024-05-04$127.51/sh450$57,38023,820.949 total
Footnotes (3)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F3]These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT